Celldex Therapeutics Begins Search for New Chief Financial Officer
Celldex Therapeutics has announced it is seeking a new Chief Financial Officer, as current CFO Sam Martin plans to retire in 2027. This move signals a structured leadership transition for the biotechnology firm. The company is preparing for a change in its financial leadership over the coming year.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.